Author:
Mikami Risako,Mizutani Koji,Ishimaru Miho,Gohda Tomohito,Iwata Takanori,Aida Jun
Abstract
AbstractThis study aims to investigate the impact of dental care utilization status on the occurrence of fatal complications such as cerebral/cardiovascular disease (CVD) and infectious diseases in patients with end-stage renal disease (ESRD) undergoing hemodialysis. This retrospective cohort study was performed using the Japanese claims database and included patients who first underwent hemodialysis between April 2014 and September 2020. The exposure variable of interest was the pattern of dental utilization, which was categorized into three groups, “dental treatment group”, “preventive dental care group”, and “no-dental visit group”. The primary outcomes were the time interval until a composite end point of first major cardiovascular event (acute myocardial infarction, heart failure, or cerebral infarction) of infectious disease (pneumonia and sepsis). The secondary outcomes were the time interval until the incidence of each component of primary outcomes. Survival analyses, including log-rank tests and Cox proportional hazards regression analyses, were performed. Among the 10,873 patients who underwent the first dialysis treatment, 6152 were assigned to the no-dental visit group, 2221 to the dental treatment group, and 2500 to the preventive dental care group. The preventive dental care group had significantly lower hazard ratios (HRs) of the incidence of CVD (adjusted hazard ratio [aHR]: 0.86, 95% confidence interval [CI]: 0.77–0.96) and infectious diseases (aHR: 0.86, 95% CI: 0.76–0.97). As for pneumonia, preventive dental care and dental treatment groups had significantly lower HRs (aHR: 0.74 and 0.80, 95% CI: 0.61–0.88, 0.66–0.96) than the no-dental visit group. This study demonstrated that dental visits for preventive dental care were associated with a significant risk reduction in CVD and infectious complications in patients with ESRD undergoing hemodialysis.
Funder
a Grant-in-Aid for Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733. https://doi.org/10.1016/s0140-6736(20)30045-3 (2020).
2. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305. https://doi.org/10.1056/NEJMoa041031 (2004).
3. Huang, S. T. et al. Intensive periodontal treatment reduces risks of hospitalization for cardiovascular disease and all-cause mortality in the hemodialysis population. J. Clin. Med. https://doi.org/10.3390/jcm7100344 (2018).
4. National Institute of Diabetes and Digestive and Kidney disease. 8. Mortality, and cause of death, H.12_HD. https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds/prior-data-reports/2019
5. Iwasaki, M. et al. Periodontal disease and pneumonia mortality in haemodialysis patients: A 7-year cohort study. J. Clin. Periodontol. 45, 38–45. https://doi.org/10.1111/jcpe.12828 (2018).